Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Migranade Migraine Relief
- Development stage
- Unknown
- Lead developer
- Migranade
- Modality
- Small Molecules
- Administration
- Oral, Intranasal
01
Overview
Migranade Migraine Relief is an over-the-counter homeopathic combination product marketed for the treatment of pain associated with migraine headaches. It is formulated as either an oral effervescent tablet or a nasal spray, each containing low homeopathic dilutions of chamomilla, natrum sulphuricum, sanguinaria canadensis, and glutathione as active ingredients, and is labeled as non-drowsy, non-habit forming, and without known drug interactions for adults and supervised children 6 years and older.[2][3][4][5]
- Brand names
- Migranade Migraine ReliefMigranade
Beyond the preview
Go deeper on Migranade Migraine Relief.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Migranade Migraine Relief.